-
-
-
-
-
-
-
IntelGenx Announces FDA’s Acceptance of Resubmitted RIZAPORT® New Drug Application
-
-
-
-
-
-
-
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines
-
-
-
-
-
-
-
RedHill Biopharma (RDHL), Grupo JUSTE Enter RIZAPORT Commercialization Term Sheet
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

